Health Care Affordability, Select 04/30/2026

Select Committee on Health Care Affordability · April 30, 2026

0:00/6:17

6:17:13

0:00

1:20:00

2:40:00

4:00:00

5:20:00

6:17:13

Call to order and logistical instructions

Presentation

0:05 → 0:54(49s)

Committee convenes; clerk called the roll and confirmed quorum. The chair (role) explained the two-day format and asked members and witnesses to focus on facts and testimony rather than policy solutions for these first sessions. Members were encouraged to submit public comments via the committee portal to be posted after the hearing.

Keywords:

Speakers:

A two-day hearing of the Select Committee on Health Care Affordability (89th Session) focused on why U.S. health care costs have risen, with expert panels addressing hospital pricing, consolidation and market power, prescription drug spending and pharmacy benefit managers (PBMs). Witnesses laid out data showing hospital prices and consolidation as primary drivers and flagged new drug categories (GLP-1s, cell/gene therapies) as emerging cost pressures.

AI-Generated Content

The text on this page is AI generated. Summaries, highlights, analysis, and video transcripts are all produced from the original source material.

AI can make mistakes, so if you spot one, and we will fix it for everyone.

Note: the source content is unaltered by us. Any content source we link to, be it a video, an audio recording, or a document, is presented exactly as its publisher released it. That publisher is usually a government body, sometimes an individual official or another organisation.

No transcript available.